$25.97
00.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Myriad Genetics
MYGNNASDAQ
Myriad Genetics (NASDAQ:MYGN) Stock, Insider Trading Activity
Myriad Genetics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Myriad Genetics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On May 15, 2024, Lee Nisley Newcomer, the company's DIRECTOR sold 6.2K shares for $25.3 each.
- On June 4, 2024, Daniel K Spiegelman, the company's DIRECTOR sold 7.58K shares for $22.04 each.
- On May 15, 2024, Paul J Diaz, the company's PRESIDENT AND CEO sold 227.84K shares for $25.14 each.
Ownership Statistics for Myriad Genetics Inc
Institutional Shares Held
54.976M
Institutional Percentage Held
60.7%
| Jun 04, 2024 | Daniel K Spiegelman | DIRECTOR | -7.58K | $22.04 | -$167.01K | SELL | -18.71% | 32.92K | Jun 03 - Jun 04 | View |
| May 15, 2024 | Paul J Diaz | PRESIDENT AND CEO | -227.84K | $25.14 | -$5.73M | SELL | -17.61% | 1.07M | May 13 - May 15 | View |
| May 15, 2024 | Lee Nisley Newcomer | DIRECTOR | -6.20K | $25.30 | -$156.86K | SELL | -8.51% | 66.65K | May 13 | View |
| Dec 05, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -30.00K | $19.09 | -$572.84K | SELL | -9.32% | 291.81K | Dec 01 | View |
| Nov 03, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -30.00K | $15.69 | -$470.62K | SELL | -8.53% | 321.81K | Nov 01 | View |
| Jun 02, 2023 | Daniel K Spiegelman | DIRECTOR | 6.51K | $23.01 | -$198.76K | GRANT | 19.17% | 40.49K | Jun 01 - Jun 02 | View |
| Mar 28, 2023 | Nicole Lambert | CHIEF OPERATING OFFICER | -6.43K | $23.48 | -$151.05K | SELL | -2.61% | 240.51K | Mar 27 | View |
| Mar 03, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -15.00K | $22.55 | -$338.25K | SELL | -4.25% | 337.88K | Mar 02 | View |
| Mar 03, 2023 | Nicole Lambert | CHIEF OPERATING OFFICER | -13.18K | $22.74 | -$299.82K | SELL | -5.77% | 215.22K | Mar 02 | View |
| Jan 23, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -9.40K | $20.04 | -$188.39K | SELL | -2.52% | 364.11K | Jan 20 | View |
| Jan 19, 2023 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -600.00 | $20.01 | -$12.01K | SELL | -0.16% | 373.51K | Jan 18 | View |
| Dec 28, 2022 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -20.00K | $15.15 | -$302.99K | SELL | -5.07% | 374.11K | Dec 27 | View |
| Jun 06, 2022 | Daniel K Spiegelman | DIRECTOR | -6.42K | $19.25 | -$123.67K | SELL | -15.90% | 33.98K | Jun 06 | View |
| Mar 01, 2022 | Jayne B Hart | CHIEF PEOPLE OFFICER | 0.00 | $24.49 | -$10.71K | SELL-OPTIONS | 0.00% | 165.88K | Feb 28 | View |
| Oct 04, 2021 | Nicole Lambert | SEE REMARKS | -1.42K | $31.57 | -$44.83K | SELL | -0.80% | 176.65K | Oct 01 | View |
| Sep 27, 2021 | Nicole Lambert | SEE REMARKS | -14.85K | $33.17 | -$492.54K | SELL | -7.70% | 178.07K | Sep 25 - Sep 27 | View |
| Sep 27, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -13.58K | $33.34 | -$452.70K | SELL | -4.70% | 275.13K | Sep 23 - Sep 26 | View |
| Sep 21, 2021 | Jayne B Hart | CHIEF PEOPLE OFFICER | 9.55K | $30.10 | -$234.55K | SELL-OPTIONS | 11.93% | 89.62K | Sep 17 | View |
| Aug 30, 2021 | Nicole Lambert | SEE REMARKS | -945.00 | $34.50 | -$32.60K | SELL | -0.74% | 127.05K | Aug 27 | View |
| Aug 25, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $31.20 | -$660.00K | SELL-OPTIONS | 0.00% | 232.55K | Aug 23 - Aug 24 | View |
| Aug 06, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $31.32 | -$239.96K | SELL-OPTIONS | 0.00% | 232.55K | Aug 05 | View |
| Aug 06, 2021 | S. Louise Phanstiel | DIRECTOR | 12.12K | $29.19 | -$277.34K | SELL-OPTIONS | 12.06% | 112.65K | Aug 05 | View |
| Aug 05, 2021 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -14.98K | $35.14 | -$526.48K | SELL | -4.41% | 324.94K | Aug 03 | View |
| Aug 05, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $30.33 | -$869.05K | SELL-OPTIONS | 0.00% | 232.55K | Aug 03 - Aug 04 | View |
| Aug 05, 2021 | Dennis Langer | DIRECTOR | 0.00 | $30.07 | -$280.80K | SELL-OPTIONS | 0.00% | 89.53K | Aug 03 | View |
| Jul 14, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $30.06 | -$666.89K | SELL-OPTIONS | 0.00% | 232.55K | Jul 12 - Jul 13 | View |
| Jul 12, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.31 | -$430.73K | SELL-OPTIONS | 0.00% | 232.55K | Jul 09 | View |
| Jul 08, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $29.38 | -$186.82K | SELL-OPTIONS | 0.00% | 232.55K | Jul 07 | View |
| Jun 30, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.95 | -$46.81K | SELL-OPTIONS | 0.00% | 232.55K | Jun 28 | View |
| Jun 28, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | -33.37K | $25.71 | -$1.69M | SELL | -12.55% | 232.55K | Jun 25 | View |
| Jun 17, 2021 | Daniel K Spiegelman | DIRECTOR | -3.14K | $30.52 | -$95.79K | SELL | -11.95% | 23.13K | Jun 17 | View |
| Jun 01, 2021 | Daniel K Spiegelman | DIRECTOR | -7.14K | $28.99 | -$207.02K | SELL | -34.73% | 13.42K | May 28 | View |
| May 05, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.72 | -$242.01K | SELL-OPTIONS | 0.00% | 265.92K | May 04 | View |
| Apr 28, 2021 | Jerry S Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $25.47 | -$480.00K | SELL-OPTIONS | 0.00% | 265.92K | Apr 27 | View |
| Apr 20, 2021 | Nicole Lambert | SEE REMARKS | -6.65K | $27.01 | -$179.59K | SELL | -4.90% | 129.12K | Apr 19 | View |
| Mar 30, 2021 | Jayne B Hart | CHIEF PEOPLE OFFICER | 0.00 | $26.14 | -$448.14K | SELL-OPTIONS | 0.00% | 80.13K | Mar 29 | View |
| Feb 17, 2021 | Jeremy S. Lanchbury | CHIEF SCIENTIFIC OFFICER | 0.00 | $23.86 | -$937.05K | SELL-OPTIONS | 0.00% | 246.57K | Feb 16 | View |
| Jan 11, 2021 | Paul Parkinson | EVP STRATEGY AND INNOVATION | -11.82K | $25.00 | -$295.60K | SELL | -13.35% | 76.75K | Jan 08 | View |
| Nov 12, 2020 | Louise S. Phanstiel | — | 15.00K | $16.62 | $249.34K | PURCHASE | 26.41% | 71.79K | Nov 11 | View |
| Sep 16, 2020 | Alexander Ford | — | -2.80K | $13.78 | -$38.63K | SELL | -1.82% | 151.16K | Sep 15 | View |
| Feb 12, 2020 | Nicole Lambert | — | -4.35K | $19.73 | -$85.91K | SELL | -6.86% | 59.15K | Feb 12 | View |
| Feb 07, 2020 | Alexander Ford | — | -7.27K | $30.00 | -$218.19K | SELL | -4.86% | 142.44K | Feb 05 | View |
| Dec 16, 2019 | Walter Gilbert | DIRECTOR | 5.86K | $25.60 | $150.00K | BUY | 12.14% | 54.15K | Dec 13 | View |
| Nov 07, 2019 | John T Henderson | DIRECTOR | 7.00K | $23.46 | $164.22K | BUY | ∞ | 2.05K | Nov 07 | View |
| Aug 02, 2019 | Mark C. Capone | PRESIDENT & C.E.O. | 0.00 | $35.19 | -$2.41M | SELL-OPTIONS | 0.00% | 440.83K | Aug 01 | View |
| Aug 02, 2019 | Gary A King | EXEC. VP INTERNATIONAL OPS | 0.00 | $33.61 | -$1.19M | SELL-OPTIONS | 0.00% | 134.87K | Aug 01 | View |
| Aug 02, 2019 | Bernard Tobin | PRESIDENT CRESCENDO BIOSCIENCE | -11.71K | $40.00 | -$468.48K | SELL | -7.42% | 146.04K | Aug 01 | View |
| Aug 02, 2019 | Richard Bryan Riggsbee | CHIEF FINANCIAL OFFICER | -25.00K | $41.50 | -$1.04M | SELL | -17.17% | 120.57K | Aug 01 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.